Humana will make investments to improve its Medicare Advantage Star Ratings, Chief Financial Officer Celeste Mellet said.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Humana Tuesday reported $1.2 billion in 2024 profits that included a $693 million fourth quarter loss as the health insurer ...

Humana depends more than other insurers on revenue from Medicare Advantage, private versions of the government’s program for ...

Humana shares slid after the health insurer said it expects Medicare Advantage memberships to decline in 2025 before the market opened Tuesday.

The cuts will mean turmoil and confusion for many beneficiaries, as well as the risk of higher premiums, fewer benefits or ...

The massive insurer now expects to lose 550,000 Medicare Advantage members — roughly one-tenth its individual MA footprint — ...

Shares of Humana Inc. were among the top 15 trending tickers on Stocktwits before the bell on Tuesday, and message volume ...

Humana's CEO, James Rechtin, emphasized that 2024 adjusted EPS met initial guidance, including investments in Stars and growth, and reaffirmed the 2025 outlook with a continued focus on achieving a 3% ...

Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share for the quarter ended December 31, 2024 (4Q24) versus the quarter ...